Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Roland Hake"'
Autor:
Thorsten H. Ecke, Paula Carolin Voß, Thorsten Schlomm, Anja Rabien, Frank Friedersdorff, Dimitri Barski, Thomas Otto, Michael Waldner, Elke Veltrup, Friederike Linden, Roland Hake, Sebastian Eidt, Jenny Roggisch, Axel Heidenreich, Constantin Rieger, Lucas Kastner, Steffen Hallmann, Stefan Koch, Ralph M. Wirtz
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 14, p 7898 (2022)
Patients with muscle-invasive urothelial carcinoma achieving pathological complete response (pCR) upon neoadjuvant chemotherapy (NAC) have improved prognosis. Molecular subtypes of bladder cancer differ markedly regarding sensitivity to cisplatin-bas
Externí odkaz:
https://doaj.org/article/508a0d38e14944d5bf0b4e1d71408b07
Autor:
Ralph M. Wirtz, Paula Carolin Voss, Frank Friedersdorff, Dimitri Barski, Thomas Otto, Michael Waldner, Elke Veltrup, Friederike Linden, Meike Schwandt, Roland Hake, Sebastian Eidt, Jenny Roggisch, Constantin Rieger, Lucas Kastner, Axel Heidenreich, Stefan Koch, Thorsten H Ecke
Publikováno v:
Journal of Clinical Oncology. 41:545-545
545 Background: Patients with muscle invasive urothelial carcinoma achieving pathological complete response (pCR) upon neoadjuvant chemotherapy (NACT) have improved prognosis. Molecular subtypes of bladder cancer differ markedly with regard to sensit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::196f5b60bad994debf353c3e69aecb5e
https://doi.org/10.1200/jco.2023.41.6_suppl.545
https://doi.org/10.1200/jco.2023.41.6_suppl.545
Autor:
Ralph M. Wirtz, Paula Carolin Voss, Frank Friedersdorff, Dimitri Barski, Thomas Otto, Michael Waldner, Elke Veltrup, Friederike Linden, Meike Schwandt, Roland Hake, Sebastian Eidt, Jenny Roggisch, Constantin Rieger, Lucas Kastner, Axel Heidenreich, Stefan Koch, Richard P. Baum, Thorsten H Ecke
Publikováno v:
Journal of Clinical Oncology. 41:543-543
543 Background: Patients with muscle invasive urothelial carcinoma achieving pathological complete response (pCR) upon neoadjuvant chemotherapy (NACT) have improved prognosis. Molecular subtypes of bladder cancer differ markedly with regard to sensit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2fea4f46e57b11d1b857ba8cb395c81
https://doi.org/10.1200/jco.2023.41.6_suppl.543
https://doi.org/10.1200/jco.2023.41.6_suppl.543
Autor:
Thorsten Ecke, Frank Friedersdorff, Elke Veltrup, Ergin Kilic, Roland Hake, Sebastian Eidt, Jenny Roggisch, Stefan Koch, Ralph M. Wirtz
Publikováno v:
Journal of Clinical Oncology. 40:560-560
560 Background: The objective of the present study was to evaluate whether preoperative standard urine parameters such as leucocyte count in urine samples dominate in particular molecular subtypes of bladder cancer and reflect the immune infiltration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4a9009713ca475d26c0f4325f4528dc
https://doi.org/10.1200/jco.2022.40.6_suppl.560
https://doi.org/10.1200/jco.2022.40.6_suppl.560
Autor:
Ralph M. Wirtz, Elke Veltrup, Hugo Prazeres, Carolina Dias, Roland Hake, Sebastian Eidt, Joao Vinagre, Jenny Roggisch, Stefan Koch, Thorsten Ecke
Publikováno v:
Journal of Clinical Oncology. 40:471-471
471 Background: The objective of the present study was to prospectively evaluate FGFR mutation detetion in matched urine and tissue samples from patients suspicious of bladder cancer and undergoing first TURB within the framework of the BRIDGister Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f865ce47a553290563dabaf4ce6fdf8
https://doi.org/10.1200/jco.2022.40.6_suppl.471
https://doi.org/10.1200/jco.2022.40.6_suppl.471
Autor:
Ralph M. Wirtz, Richard Watts, Ronny Kellner, Reinhard Ortmann, Torsten Horns, Daniel Enderle, Lisa Meyer, Mikkel Noerholm, Mario Morken, Elke Veltrup, Roland Hake, Sebastian Eidt, Jenny Roggisch, Stefan Koch, Thorsten Ecke
Publikováno v:
Journal of Clinical Oncology. 40:469-469
469 Background: The objective of the present study was to assess FGFR mutattions and fusions from matched urine and tissue samples from patients suspicious of bladder cancer and undergoing first TURB within BRIDGister RealWorld Experience trial. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07b74acd39bd31364e82c41ed3bcdfc7
https://doi.org/10.1200/jco.2022.40.6_suppl.469
https://doi.org/10.1200/jco.2022.40.6_suppl.469
Autor:
Elke Veltrup, Torsten Horns, Daniel Enderle, Sebastian Eidt, Thorsten H. Ecke, Ralph M. Wirtz, Mikkel Noerholm, Richard Watts, Roland Hake, Ronny Kellner, Reinhard Ortmann, Stefan Koch, Lisa Meyer, Jenny Roggisch, Mario Morken
Publikováno v:
Journal of Clinical Oncology. 39:e16532-e16532
e16532 Background: The objective of the present study was to assess FGFR mutattions and fusions from matched urine and tissue samples from patients suspicious of bladder cancer and undergoing first TURB at the pilot center of the multicentric BRIDGis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da943204c1ab355ebae0e754c516deee
https://doi.org/10.1200/jco.2021.39.15_suppl.e16532
https://doi.org/10.1200/jco.2021.39.15_suppl.e16532
Autor:
Jenny Roggisch, Ronny Kellner, Stefan Koch, Thorsten H. Ecke, Roland Hake, Richard Watts, Frank Friedersdorff, Ralph M. Wirtz, Elke Veltrup, Ergin Kilic, Sebastian Eidt
Publikováno v:
Journal of Clinical Oncology. 39:e16533-e16533
e16533 Background: The objective of the present study was to identify molecular charactersitics associated with FGFR positive tumors in matched urine and TUR biopsy samples from patients being suspicious of bladder cancer and undergoing first TURB at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c2dcc46afeee4c29a69d2a13439218f
https://doi.org/10.1200/jco.2021.39.15_suppl.e16533
https://doi.org/10.1200/jco.2021.39.15_suppl.e16533
Autor:
Pascal Scherwitz, Dirk L. Stippel, Hans A. Schlößer, Anne Fiedler, Roland Hake, Alexander Shimabukuro-Vornhagen, Thomas C. Koslowsky, Maria Garcia-Marquez, Till Herbold, Luise Gryschok, Sebastian Eidt, Laura S. Neuhaus, Michael Hallek, Joke Malcher, Michael von Bergwelt-Baildon, Kerstin Wennhold, Sebastian Theurich, Hans Jiro Becker, Arnulf H. Hoelscher
Publikováno v:
Oncotarget
$('.header-date').hide();$('#titleAuthors').hide(); $('#abstractHeader').hide(); Alexander Shimabukuro-Vornhagen 1 , 2 , * , Hans A. Schloser 1 , 3 , * , Luise Gryschok 1 , Joke Malcher 1 , Kerstin Wennhold 1 , Maria Garcia-Marquez 1 , Till Herbold 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fdcc70d47ec0c18dde3bc123356d5c7
https://pubmed.ncbi.nlm.nih.gov/25026291
https://pubmed.ncbi.nlm.nih.gov/25026291
Autor:
Roland Hake, Hans-Peter Sinn, Frederik Marmé, Mark Laible, Ralph M. Wirtz, Andreas Schneeweiss, Kornelia Schlombs, Iris Scheffen, Sebastian Eidt, Claudia Schumacher
Publikováno v:
Journal of Clinical Oncology. 34:e12045-e12045
e12045Background: Ultrahigh ESR1 mRNA expression in luminal breast tumors is predictive for benefit from adjuvant tamoxifen compared to placebo treatment in NSABP B14, while protein determination b...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c08685ae46173481afc1e96ac82bd14
https://doi.org/10.1200/jco.2016.34.15_suppl.e12045
https://doi.org/10.1200/jco.2016.34.15_suppl.e12045